We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Varex Imaging

Varex Imaging Corporation is a leading independent supplier of medical X-ray tubes and image processing solutions. Fr... read more Featured Products: More products

Download Mobile App




Portuguese Cancer Center Becomes World’s First to Offer Innovative Radiosurgery Application

By HospiMedica International staff writers
Posted on 20 Mar 2014
Prostate, lung, and brain cancer patients in Portugal will now benefit from cutting-edge radiosurgery technology.

Physicians from the Champalimaud Center for the Unknown (Lisbon, Portugal) have performed the world’s first cancer treatments using the new advanced Edge radiosurgery system from Varian Medical Systems (Palo Alto, CA, USA). More...
This fast, precise, and noninvasive alternative to traditional surgery was used to treat several patients with prostate, lung, and brain tumors.

The Edge radiosurgery system enables clinicians to attack tumors from outside the body using carefully shaped high-energy X-rays. There are no incisions and patients contend with few of the healing, pain, and recovery issues associated with conventional surgery. Targeting precision is enabled by Varian’s Calypso “GPS for the Body” system for tracking tumor position in real time. The system also can alert clinicians if a patient has moved in a way that could compromise treatment accuracy. A sophisticated treatment couch with six axes of motion enhances treatment precision by providing additional angles for targeting tumors.

“Edge radiosurgery should make a big difference in the precision of treatments, particularly with the advanced PerfectPitch couch system, which offers us the ability to make minute positional corrections efficiently,” stated Prof. Carlo Greco of the Champalimaud Foundation. “We are delighted to be the first center in the world to begin clinical treatments using Edge radiosurgery and it has been a superb job by the whole Varian and Champalimaud teams to make this happen.”

The first patient treated at Champalimaud using Edge Radiosurgery was a 63-year-old female with operable stage 1 non-small-cell lung cancer. Clinicians also treated a 67-year-old male with two metastatic tumors in his brain. He received radiosurgery for both tumors in a single session that took less than 10 minutes.

The center also used the Edge system to begin hypofractionated stereotactic ablative body radiotherapy for two prostate cancer patients, enabling them to complete the treatments in five sessions, rather than the 30-40 sessions that are typically required with standard radiotherapy. According to the clinicians at Champalimaud, early data indicate that hypofractionation holds great potential in achieving excellent tumor control for properly selected prostate cancer patients.

“We believe the Edge radiosurgery system offers more options for clinicians and will prove to be an effective tool for effectively performing cancer surgery with no knife,” said Rolf Staehelin, head of international marketing for Varian Medical Systems.

Other leading cancer centers worldwide, including the Henry Ford Clinic (Detroit, MI, USA) and the Humanitas Clinic (Milan, Italy) are scheduled to begin treatments using the Edge Radiosurgery system in the coming weeks.

Related Links:

Champalimaud Center for the Unknown 
Varian Medical Systems



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.